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Long-term effects e ~ the protein kina~e C act ivat ing phorbo l  ester, TPA,  on  mt ick -ceB prol i ferat i3n and insulin product ion were invest igated 
It ~as  found that  ~-cell repl ication and long-term insulin secretion were enhanced in - i 'PA-treated islets. This was not accompanied by a 
corresponding increase in (pro)insul in biosynthesis, presumably contr ibut ing to the lowered islet insulin exmtent. TPA also increased islet polyamine 
content  but when this in~s¢ was prevented by blocking po lyamme synthesis, DNA replication apd insulin secretion remained elevated. These 
f indings indicate that TPA stimulates f l -~l l  replication and insulin secretion and suggest a st imulatory role for protein k ina~ C, bnt not for 
polyamines, in these processes. 
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1. INTRODUCTION 
A l im i ted  number  o f  substances  have  emerged as  
s t imu la tors  o f  pancreat ic  i s le t  ce l l  p ro l i fe ra t ion  in  v i t ro  
( rev iewed by  He l le rs t r6m and Swenne [1]) .  Some o f  
these  fac tors ,  e .g .  g lucose  and  po ly lmpt ide  growth  
fac tors ,  a re  known in  ~8-c~lls o r  o ther  t i ssues  to  enhance  
the  act iv i ty  o f  p ro te in  k inase  C (PKC)  [2 ,3] .  Th is  phos -  
pho l ip id -  and  Caa+-dcpendent  enzyme is  ac t ivated  by  
d iacy lg lyccro l  wh ich  is  fo rmed dur ing  agon is t - induced 
po lyphosp l :o inos i t ide  hydro lys i s  [4] ,  an  eve ,~t  that  
occurs  ear ly  in  t ransduct ion  o f  the  mi togen ic  s i#:a!  [3]. 
PKC act ivat ion  subsequent ly  leads  to  phosphory la t ion  
o f  the  Na+/H ÷ ant ipor ter  in  the  p lasma membrane 
wh ich  resu l t s  in  in t race l lu la r  a lka l in i za t ion  [5]. PKC 
act iv i ty  is  sub jec t  to  s t imu la t ion  not  on ly  by  the  en-  
dogenous  compound d iacy lg lycero l ,  but  a l so  by  tumor -  
p romot ing  phorbo l  es ters ,  such  as  12-O- te t radecanoy i -  
phorbo l  13-acetate  (TPA)  [4]. TPA  is w ide ly  used  as  an  
insu l in  secretagogue in  the  ~-c~l l  [6],  l~.ut i t s  putat ive  
long- term impact  on  ~-c~l l  p ro l i fe ra t ion  and  insu l in  
p roduct ion  has  not  p rev ious ly  been  s tud ied .  I~ was  the  
a im o f  th i s  invest igat ion ,  by  us ing  TPA,  to  d i rec t ly  
s tudy  the  ro le  o f  PKC in  the  regu la t ion  o f  f l- ,~ell  p ro -  
i i fe ra t ion  and  hormone syr thes is .  Th~ e f fec t  o f  the  
phorbo l  es ter  on  the  ~B-c~ll content  o f  po l>amines  was  
a l so  ana lyzed ,  s ince  these  substances  have  been shown 
to  be  invo lved  in  pro l i fe ra t ion  and  t~3acromolecu lar  ~yn-  
thes is  by  the  f l - ce l l s  [7 ,8]  and  numberous  o ther  t i ssues  
[9]. 
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2. MATERIALS  AND METHODS 
2. !. Materials 
DFMO was generously g ivm by Dr. Peter P. McCarm at Merrell  
Bow Research Center, Cincinnati ,  OH,  USA.  Dr.  Juhan i  J~nne, Uni -  
versily of  Helsinki, F inland. kindly provided EGBG.  TPA was from 
S iVa  a-~d wa~ di.%~.'-..~! i~ absolute thanol  at a ¢on~nt la t i cn  of 10 
mM and further 0iluted in DMSO to stock solutions of  100/~M. AI| 
test groups re~ived  equal amoutds of  ¢~t~lvent (0.01•, v/v). 
2.2. Methods 
Pregnant Spraguc-Da :"Icy rats beiong, ing to a local stock were it illed 
by cervical dis location on day 21 of  gestation and  the fetuses rapidly 
removed. Fetal rat islets were prepared from pancreatic glands as 
previoufly described |10]. At  the end of  the 5-day culture period 
groups of  50 islets were transfi:rred to fresh media contain ing i % fetal 
calf serum, with or  wi thout  10 nM 17PA and polyamine synthesis 
inhibitors, and cultured f r t~f loat ing for 3 days. 
In this study inhibitors of  key enzymes in polyamine b iosynth~is  
were emploTed, viz. difluor,mmethylornithine (DFMO)  and ethyl- 
glyoxal bls(guanylhydrazone) (EGBG).  DFMO is a specific and  irre- 
versible inhibi tor  of  ornithine __~_~boxylase, the enzyme regulating 
put re~ine  format ion [1 !]. IEG~ is a highly selective and potent,  
albeit not completely specific, inhibitor  o f  S-adenosyimethionine de-
carboxylase, which controls  ynthesis of  spermidine and  spermine [! 2l- 
Compar isons were made only hetween control  islets and islets treala~l 
with DFMO+EGBG.  This was done because we have previously 
shove. [81 that ornith ine decarboxylase inhibit ion by DFMO results 
in partial deplet ion of  putrescit~ aad spetrnidine, while leaving 
~permine levels tm~ffected, and that  thi~ decree_ ¢~- does not  affect 
insul in product ima or  f l -cel l  growth.  
The  methods  fo r  analyz lng the islet po lyamlne  content  ,~?,8,13], 
DNA synthesis [8]. DNA content |1435],  (lmro)insulin biosynthesis 
and secretion [7,16-18] have been publ ished previously. 
3. RESULTS 
As  shown in  Tab le  1 exposure  o f  fe ta l  ra t  i s le ts  fo r  3 
days  to  10 nM TPA resu l ted  in  a br i sk  s t imu la t ion  o f  
DNA synthes is ,  as  measured  by  [3H] thymid ine  in -  
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Table ! 
Effect of TPA and polyamine synthesis inhibitorg on islet DNA syrlthe~is and polya- 
mine content 
Islet cultuTe DNA synthesis 
,% of control) 
Polyamine content g% of  control) 
Spermidine Spermine 
Control 100 100 100 
TPA (10 nMI 201 ± 20* 162 ± 18" 138 ± !1" 
TPA + DI~MO(5 raM) 210 +- 35* 96 ± 14 144 ± 16" 
TPA-e  DFMO + EGBG 185 _+ 25* 91 ± 11 103 ± 7 
(100/~M) 
Fetal rat islets were cultured for 3 days in medium RPM!  1640 containing 1% fetal 
calf serum and supplemented asindicated in the Table. Values are expressed as mean 
peroent of  controls _+ SEM for 5-6 observations. *denotes P < 0.05 for chance 
d.;ffcrences v . control islets using Student's paired ~-test. ControI values were: Di~,~A 
synthesis, t 160 -+218 cpm/~g DNA: polyamine content, 93 ± 25 pmol//~g DiqA and 
73 _+ 16 pmol/~tg DNA (n=6) for spermidine and spcrminc, respectively. 
corporat ion  in to  DNA.  Th is  inc rease  in DNA synthes is  
was  not  a l te red  when inh ib i to rs  o f  po lyamine  b io -  
synthes is  (5 mM DFMO + 100/ tM EGBG)  were  added 
a long  w i th  the  phorbo l  est~.r. The  i s le t  DNA content  
was  not  a f fec ted  by  TPA,  DFMO or  EGBG (not  
shown) ,  averag ing  12--+2 ng / i s le t .  
Fo l low ing  a 3 -day  exposure  to  i0  nM o f  TPA,  the  
is let  po lyamine  content  was  ,ncreased  when compared  
w i th  cont ro l s  (Tab le  !). lne - 'us ion  o f  DFMO (5 raM)  
a long  w i th  the  phorbo i  es ter  ob l i te ra ted  the  increase  in  
spermid ine ,  whereas  the  e leva=ed spermine  content  per -  
i s ted  un less  EGBG (100/~M} was  added as  we l l .  When 
,a-cel l  insu l in  p roduct ion  was  examined a f te r  a 3 -day  
exposure  to  TPA (10 nM) ,  it was  found that  (p ro ) insu l in  
b iosynthes is  was  not  a f fec ted  by  the  phorbo l  es ter  
tTab le  I I ) .  On  the  o ther  hand,  to ta l  p ro te in  synthes is  
was  s ign i f i cant ly  suppressed  in TPA- t reated  is le ts .  Con-  
sequent ly ,  the  f rac t ion  (pro ) insu l in  synthes ized  o f  to ta l  
p ro te in  was  e levated  in TPA- t reated  is le ts .  TPA  t reat -  
ment  reduced  the  is let  insu l in  content  (Tab le  I) and  
fu r ther  enhanced the  accumulat ion  o f  insu l in  in  the  cu~- 
tu re  med ium.  Th is  s t imu la tory  e f fec t  o f  TPA  on  insu l in  
se~=retion was  not  impeded at  al l  by  the  s imu l taneous  
inc lus ion  o f  DFMO (5 mM)  + EGBG (100/ /M)  (not  
shown) .  A shor t - te rm g lucose  cha l lenge  a t  the  end  o f  the  
cu l tu re  per iod  revea led  a prompt  insu l in  secretory  
response  to  16.7 mM g lucose  in unt reated  i s le ts ,  
whereas  in  TPA- t reated  ce l l s  there  was  a par t ia l  
a t tenuat ion  o f  the  g lucose-sens i t i ve  insu l in  secret ion  
(Tab le  I I ) .  The  basa l  insu l in  re lease  ( in  1.67 mM 
g lucose)  was  not  a l te red  by  TPA t reatment .  
4. D ISCUSSION 
The  ca lc ium-  and  phospho l ip id -dependent  pro te in  
k inase  C (PKC)  has  emerged as  a p le io t rop ic  regu la tor  
o f  var ious  ce l lu la r  funct ions ,  inc lud ing  ce l l  p ro l i fe ra t ion  
and  hormone s~ret ion  [4]. Th is  enzyme has  been  
ident i f ied  as  the  ce l lu la r  receptor  fo r  tumor -promot ing  
phorbo l  es ters  such  as  TPA [4]. The  s ign i f i cance  o f  PKC 
in  regu la t ion  o fce l l  p ro l i fe ra t ion  and  hormone secret ion  
is amply  i l l us t ra ted  by  the  combined  f ind ings  o f  potent  
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Table II 
Eff~:ts of TPA on islet insulin production 
Isle,, culture 
Control TPA (10 nM) 
{Pro)insulin biosynthesis (10-3 × dpm/h per 10 islets) 
Total protein biosynthesis { 10 -3 × dpm/h per I 0 islets) 
(ProJinsulin biosynthesis I~ib of  total protein biosynthesis) 
lnsuhn content (rig/10 islets) 
Insulin accumulation (% of  control) 
Insulin release in 1.67 mM glucose (ng/h per 10 islets} 
Insulin release in 16.7 mM glucose (ng/h per 10 islets} 
8.7_+ 1.3 9.9 ± 1.2 
83 _+ 23 26 ± 2.6* 
18 _+ 7 39 ± 5* 
339_+ 75 120+ 14" 
100 399 _+ 87* 
4.0_+ 0.7 3.9_+0.5 
47 ± 5 32 ± 3" 
Control ct:ltures accumulated 88 +_26 ng insulin per 10 islets per ml during the 3-day 
culture period. Values are means _+ SEM for 5-6 observations. *denotes P < 0.05 for 
a chance difference vs. controls using Student's paired t-test. 
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mi togen ic  and  secre*.'sry (and  in some cases  tumor i -  
gen ic )  ac t ions  o f  TPA and  i r . l~b i to rs  o f  d iacy lg lycero l  
degradat ion ,  and  the  la rge  increases  in PKC act iv i ty  
occur r ing  in response  to  natura l  mi togens  and  secre -  
tagogues  [2.3]. Fur ther  ev idenoe  fo r  a c ruc ia l  ro le  o f  
PKC in  normal  and  neop las t i c  p ro l i fe ra t ion  is der ived  
f rom f ind ings  o f  e levated  d iacy lg lycero l  leve ls  o r  PKC 
act iv i ty  in c -Ha- ras - t rans for rned  ce l ls  [19,20] and  that  a 
mutant  PKC obta ined  f rom f ib rosarcoma ce l l s  ns ab le  
to  induce  neop las t i c  t rans format ion  o f  normal  fi- 
b rob las ts  [21 ]. 
Apar t  f rom s tud ies  concerned w i th  the  s ign i f i cance  o f  
PKC in regu la t ion  o f  p -ce l l  ac t iv i ty  in  the  shor t - te rm 
[2,6,22],  repor ts  on  the  long- term in f luence  o f  PKC 
s t imu la t ion  are  scarce .  However ,  Schwizer  [23] found 
that  exposure  o f  i s le ts  i so la ted  f rom newborn  ra ts  to  
TPA fo r  up  to  one  month  enhanced the  insu l in  content  
o f  these  is lets  as  we l l  as  insu l in  output ,  w i thout  a f fec t ing  
the  number  o f  is let  ce i ls .  In  another ,  more  recent  s tudy  
[24] no  e f fec ts  o f  TPA were  found on  the  g )NA synthes is  
o f  fe ta l  ra t  i s let  ce l l  suspens ions ,  desp i te  s t imu la t ion  o f  
insu l in  seoret ion  f rom these  ce l ls .  The  f ind ings  presented  
here  conf i rm that  TPA provokes  secret ion  o f  insu l in  
f rom the  p -ce l l s ,  and  a l so  suggest  that  the  phorbo i  es ter  
t reatment  leads  to  s t imu la t ion  o f  p -ce l l  rep l i ca t ion .  Be-  
cause  i s le ts  p repared  accord ing  to  the  present ly  
employed techn ique  conta in  >90% t -ce l l s  i t  seems rea-  
sonab le  to  assume that  the  resu l t s  a re  representat ive  o f  
th i s  par t i cu la r  cel l  type  [10]. In  add i t ion ,  incorporat ion  
o f  [aH] thymid ine  over  a 5 -h  labe l ing  per iod  has  been 
shown to  represent  p -ce l l  mi to t i c  ac t iv i ty  [25]. Because  
p -ce l l s  have  a long  ce l l  cyc le  [25], i t  was  cons idered  
necessary  to  expose  the  i s le ts  to  phorbo l  es ter  fo r  3 days  
in o rder  to  a l low DNA synthes is  in i t ia ted  pr io r  to  TPA 
add i t ion  to  be  te rminated  before  [3H] thymid ine  add i -  
t ion .  The  feta l  i s le ts  do  not  respond rn i togc~aca l ly  to  
f ib rob las t  mi togens  [8], ind icat ing  lack  o f  mes¢_qchymal  
contaminat ion  that  might  o therwise  be  expected  to  
obscure  t i c .e l l  DNA synthes is .  There  are  apparent  d i s -  
c repanc ies  between the  present  f ind ings  and  the  above-  
ment ioned repor ts .  However ,  in th i s  s tudy  a low con-  
cent ra t ion  o f  phorbo l  es ter ,  wh ich  was  cons idered  spe-  
c i f ic  fo r  PKC act ivat ion  [4] was  used ,  wh ich  cou ld  ex -  
p la in  the  d i f fe rences  in outcome between th i s  s tudy  and  
that  o f  Mourmeaux et  a l .  [24]. In  add i t ion ,  the  la t te r  
authors  u t i l i zed  suspens ions  o f  is let  ce l l s  i so la ted  d i -  
rec t ly  f rom fe ta l  pancreas ,  the  pur i ty  o f  wh ich  had  not  
been  character i zed .  The  d isc repancy  between the  pres -  
ent  f ind ings  and  those  o f  Schwizer  [23], who  fa i led  to  
detect  any  long- term ef fect  o f  TPA (10  aM)  on  is let  ce l l  
number ,  may be  accounted  fo r  by  an  enhanced turnover  
ra te  o f  ce l l s  exposed  to  TPA.  wh ich  thereby  wou ld  
obscure  the  mi togen ic i ty  o f  the  phorbo l  es ter .  A l though 
pro longed exposure  to  h igh  concent ra t ions  o f  " IPA  
eventua l ly  w i l l  l ead  to  PKC down- regu la t ion ,  s.och 
changes  in enzyme act iv i ty  arc. d i f f i cu l t  to  re la te  conc lu -  
s ive ly  to  changes  in p -ce l l  rep l i ca t ion  and  po lyamine  
content ,  wh ich  occur  over  10-24  h_ Nonethe less ,  g iven 
the  combined  fac ts  that  PKC overexpress ion  confers  an  
en,  anced  growth  ra te  (and  in some cases  neop las t i c  
t r~,-~sformat~on) i  o ther  t i ssues ,  and  that  known t -ce l l  
mi to :~ens  t rans ient ly  ac t ivate  PKC [2 ,3 ,19-21] ,  it is 
tike;~, that  the  present ly  observed  mi togen ic i ty  c f  TPA 
indeed re f lects  PKC act ivat ion ,  in  add i t ion ,  expos-~re o f  
feta l  i s le ts  to  the  h igh ly  spec i f ic  rKC  inh ib i to r ,  H -7 ,  
resu l t s  in an  a lmost  to ta l  inh ib i t ion  of~0-cel l  rep l i ca t ion  
(Ake  S jOho lm.  unpub l i shed) ,  a f ind ing  wh ich  is con-  
s i s tent  w i th  the  proposed  ro te  o f  PKC as  a s t imu la tor  
o f  t - ce l l  rep l i ca t ion .  
To  my knowledge the  present  repor t  repre.~ents the  
f i rst  a t tempt  to  d i rec t ly  invest igate  :he  impact  o f  TPA 
on  p -ce l l  insu l in  product ion  The  f ind ings  ind icate  that  
the  potent  secretagog ic  ac t ion  o f  TPA was  not  com-  
pensated  fo r  by  a cor respond ing  increase  in insu l in  b io -  
synthes is ,  thus  l i ke ly  cont r ibut ing  to  the  decreased  in-  
su l in  content  in is lets  exposed  to  the  drug .  By the  same 
token ,  the  in lpa i rmen(  o f  g lucose-sens i t :ve  insu! in  secre-  
t ion ,  that  occur red  a f te r  TPA t reatment ,  l i ke ly  re f lects  
the  lowered  insu l in  content .  
I~ search  fo r  poss ib le  in t racd lu la r  med ia tors  o f  the  
mi togen ic  and  secretagog ic  ac t ions  o f  TPA,  ~his s tudy  
focused  on  the  ro le  o f  po lyamines .  Th is  was  done  be-  
cause  these  organ ic  cat ions  have  prev ious ly  been impl i -  
ca ted  in the  regu la t ion  o f  p -ce l l  p ro l i fe ra t ion  and  
hormone secret ion  [7,8]. A l so ,  it is we l l  known that  
inc reases  in  po lyamine  b iosynthes is  occur  whenever  cel l  
p ro l i fe ra t ion  is s t imu la ted  [9]. The  resu l ts  show the  ex -  
pected  increase  in is let  po lyamine  content  in response  
to  TPA,  thereby  suppor t ing  the  concept  o f  a un iversa l  
accompan iment  o f  ce l l  p ro l i fe ra t ion  by  po lyamine  b io -  
synthes is .  However ,  when at tempts  were  made to  e lu -  
c idate  the  impor tance  o f  th-s  inc rease  in po lyamincs  by  
the  use  o f  h igh ly  se lec t ive  inh ib i to rs  o f  key  po lyamine  
synthes iz ing  enzwmes,  it tu rned  out  that  the  mi toge-  
n ic i ty  and  secretory  ac t iv i ty  o f  TPA pers i s ted  desp i te  
prevent ion  o f  the  increases  in po lyamines  in who le  
is lets.  Th is  wou ld  argue  aga ins t  a s ign i f i cant  ro le  fo r  
po lyamines  in convey ing  the  messages  o f  TPA.  
In  summary ,  the  resu l t s  p resented  here  inP icate  that  
spec i f i c  PKC act ivat ion  s t imu la tes  not  on ly  insu l in  
secret ion  but  a l so  p -ce l l  DNA synthes is ,  and  moreover  
suggest  a lack  o f  par t i c ipat ion  o f  po lyamines  in modu la -  
t ion  o f  these  processes .  It  is suggested  that  PKC act iva -  
t ion  may be  an  impor tant  event  in t ransduc ing  the  mi to -  
gen ic  s igna l  o f  g lucose  and  po lypept idc  growth  fac tors .  
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